BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 872 filers reported holding BAXTER INTL INC in Q2 2016. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201 | -29.7% | 5,323 | -15.2% | 0.04% | -30.5% |
| Q2 2023 | $286 | -6.8% | 6,277 | -17.1% | 0.06% | -13.2% |
| Q1 2023 | $307 | -29.6% | 7,572 | -11.4% | 0.07% | -27.7% |
| Q4 2022 | $436 | -99.9% | 8,550 | -13.8% | 0.09% | -31.9% |
| Q3 2022 | $534,000 | -16.2% | 9,922 | 0.0% | 0.14% | -11.5% |
| Q2 2022 | $637,000 | -21.8% | 9,922 | -5.6% | 0.16% | -10.9% |
| Q1 2022 | $815,000 | -11.4% | 10,507 | -2.0% | 0.18% | -11.2% |
| Q4 2021 | $920,000 | +6.4% | 10,722 | -0.3% | 0.20% | -1.5% |
| Q3 2021 | $865,000 | -8.0% | 10,758 | -7.9% | 0.20% | -28.8% |
| Q2 2021 | $940,000 | -7.9% | 11,687 | -3.4% | 0.28% | +19.1% |
| Q1 2021 | $1,021,000 | +5.1% | 12,102 | -0.0% | 0.24% | -2.1% |
| Q4 2020 | $971,000 | +3.3% | 12,103 | +3.6% | 0.24% | -14.2% |
| Q3 2020 | $940,000 | -8.9% | 11,687 | -2.5% | 0.28% | -14.1% |
| Q2 2020 | $1,032,000 | -1.0% | 11,988 | -6.5% | 0.33% | -7.6% |
| Q1 2020 | $1,042,000 | -0.5% | 12,828 | +2.4% | 0.35% | +18.0% |
| Q4 2019 | $1,047,000 | -4.6% | 12,523 | -0.2% | 0.30% | -12.0% |
| Q3 2019 | $1,098,000 | +3.7% | 12,548 | -2.9% | 0.34% | +1.5% |
| Q2 2019 | $1,059,000 | +0.9% | 12,926 | +0.1% | 0.34% | -2.9% |
| Q1 2019 | $1,050,000 | +17.4% | 12,910 | -5.0% | 0.35% | +7.1% |
| Q4 2018 | $894,000 | -16.6% | 13,588 | -2.3% | 0.32% | -3.6% |
| Q3 2018 | $1,072,000 | +2.3% | 13,910 | -2.0% | 0.34% | -2.9% |
| Q2 2018 | $1,048,000 | +7.4% | 14,199 | -5.4% | 0.34% | +14.2% |
| Q1 2018 | $976,000 | +4.6% | 15,004 | +4.0% | 0.30% | -2.9% |
| Q4 2017 | $933,000 | +2.5% | 14,429 | -0.6% | 0.31% | -2.2% |
| Q3 2017 | $910,000 | -0.4% | 14,509 | -3.9% | 0.32% | -5.9% |
| Q2 2017 | $914,000 | +11.1% | 15,092 | -4.9% | 0.34% | +2.7% |
| Q1 2017 | $823,000 | -99.9% | 15,864 | 0.0% | 0.33% | +8.2% |
| Q4 2016 | $703,410,000 | +92332.3% | 15,864 | -0.7% | 0.30% | -13.9% |
| Q3 2016 | $761,000 | +2.6% | 15,979 | -2.7% | 0.35% | +5.1% |
| Q2 2016 | $742,000 | +9.6% | 16,419 | -0.4% | 0.34% | +9.8% |
| Q1 2016 | $677,000 | +3.7% | 16,479 | -3.7% | 0.31% | +3.4% |
| Q4 2015 | $653,000 | +16.2% | 17,114 | 0.0% | 0.30% | +9.6% |
| Q3 2015 | $562,000 | -55.2% | 17,114 | -4.6% | 0.27% | -49.5% |
| Q2 2015 | $1,254,000 | +3.0% | 17,934 | +0.9% | 0.54% | +4.1% |
| Q1 2015 | $1,218,000 | -5.0% | 17,774 | +1.6% | 0.51% | -6.5% |
| Q4 2014 | $1,282,000 | +2.2% | 17,494 | +0.1% | 0.55% | -3.2% |
| Q3 2014 | $1,254,000 | +3.8% | 17,479 | +4.6% | 0.57% | +2.2% |
| Q2 2014 | $1,208,000 | +0.4% | 16,709 | +2.2% | 0.56% | -1.9% |
| Q1 2014 | $1,203,000 | +5.6% | 16,354 | -0.2% | 0.57% | +3.7% |
| Q4 2013 | $1,139,000 | +4.6% | 16,379 | -1.2% | 0.55% | -0.9% |
| Q3 2013 | $1,089,000 | -5.6% | 16,579 | -0.5% | 0.55% | -12.5% |
| Q2 2013 | $1,154,000 | – | 16,657 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |